Advisor Group Holdings Inc. acquired a new position in shares of LifeVantage Corp (NASDAQ:LFVN) during the first quarter, HoldingsChannel reports. The fund acquired 6,771 shares of the company’s stock, valued at approximately $69,000.
A number of other large investors also recently modified their holdings of the business. AQR Capital Management LLC grew its holdings in LifeVantage by 129.4% during the 1st quarter. AQR Capital Management LLC now owns 37,203 shares of the company’s stock worth $383,000 after acquiring an additional 20,982 shares during the last quarter. Two Sigma Investments LP bought a new position in shares of LifeVantage in the 1st quarter valued at about $157,000. Two Sigma Advisers LP boosted its stake in shares of LifeVantage by 34.1% in the 1st quarter. Two Sigma Advisers LP now owns 17,972 shares of the company’s stock valued at $185,000 after purchasing an additional 4,572 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of LifeVantage by 7.0% in the 1st quarter. Wells Fargo & Company MN now owns 28,400 shares of the company’s stock valued at $292,000 after purchasing an additional 1,855 shares during the last quarter. Finally, Nuveen Asset Management LLC boosted its stake in shares of LifeVantage by 7.4% in the 1st quarter. Nuveen Asset Management LLC now owns 102,795 shares of the company’s stock valued at $1,059,000 after purchasing an additional 7,120 shares during the last quarter. 47.65% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ LFVN opened at $12.84 on Friday. The firm has a market capitalization of $183.74 million, a PE ratio of 16.25 and a beta of 1.36. LifeVantage Corp has a 1 year low of $7.75 and a 1 year high of $17.25. The firm’s 50-day moving average is $13.62 and its 200-day moving average is $13.71.
In related news, CEO Darren Jay Jensen sold 4,500 shares of the stock in a transaction that occurred on Wednesday, July 15th. The shares were sold at an average price of $13.50, for a total value of $60,750.00. Following the sale, the chief executive officer now directly owns 472,138 shares in the company, valued at approximately $6,373,863. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold a total of 11,500 shares of company stock worth $160,783 over the last quarter. 6.80% of the stock is currently owned by corporate insiders.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Featured Story: Straddles
Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeVantage Corp (NASDAQ:LFVN).
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.